Miranda V. Van Eck-Eck

Leiden, ZH 2333AL, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.

Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.

Journal: Cell reports

Published: November 14, 2025

Bone Marrow Farnesoid X Receptor Deficiency Does Not Impact Atherosclerosis Susceptibility in Male Low-Density Lipoprotein Receptor Knockout Mice.

Bone Marrow Farnesoid X Receptor Deficiency Does Not Impact Atherosclerosis Susceptibility in Male Low-Density Lipoprotein Receptor Knockout Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 10, 2025

SR-BI Models for Spontaneous Myocardial Infarction: High Unesterified/Total Cholesterol Ratio Not the Sole Piece of the Puzzle.

SR-BI Models for Spontaneous Myocardial Infarction: High Unesterified/Total Cholesterol Ratio Not the Sole Piece of the Puzzle.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: November 27, 2024

Enhanced B-1 self-renewal and attenuated atherosclerotic lesion development in Cd19cre/+Ldlr-/- mice on Western-type diet.

Enhanced B-1 self-renewal and attenuated atherosclerotic lesion development in Cd19cre/+Ldlr-/- mice on Western-type diet.

Journal: Atherosclerosis

Published: July 16, 2024

Gene Editing for the Treatment of Hypercholesterolemia.

Gene Editing for the Treatment of Hypercholesterolemia.

Journal: Current atherosclerosis reports

Published: March 11, 2024

LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice.

LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice.

Journal: Biomolecules

Published: February 21, 2024

Recombinant human proteoglycan 4 lowers inflammation and atherosclerosis susceptibility in female low-density lipoprotein receptor knockout mice.

Recombinant human proteoglycan 4 lowers inflammation and atherosclerosis susceptibility in female low-density lipoprotein receptor knockout mice.

Journal: The Journal of physiology

Published: January 29, 2024

Scavenger Receptor BI Deficiency in Mice Is Associated With Plasma Ceramide and Sphingomyelin Accumulation and a Reduced Cholesteryl Ester Fatty Acid Length and Unsaturation Degree.

Scavenger Receptor BI Deficiency in Mice Is Associated With Plasma Ceramide and Sphingomyelin Accumulation and a Reduced Cholesteryl Ester Fatty Acid Length and Unsaturation Degree.

Journal: Journal of lipid and atherosclerosis

Published: August 25, 2023

Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility.

Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility.

Journal: Biomolecules

Published: August 04, 2023

High-density lipoproteins and non-alcoholic fatty liver disease.

High-density lipoproteins and non-alcoholic fatty liver disease.

Journal: Atherosclerosis plus

Published: June 06, 2023

Perspective: Hepatocyte-Directed Base Editing as Novel Treatment for Human Dyslipidemia-Current Status and Remaining Challenges.

Perspective: Hepatocyte-Directed Base Editing as Novel Treatment for Human Dyslipidemia-Current Status and Remaining Challenges.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 02, 2023

Specific Loss of ABCA1 (ATP-Binding Cassette Transporter A1) Suppresses TCR (T-Cell Receptor) Signaling and Provides Protection Against Atherosclerosis.

Specific Loss of ABCA1 (ATP-Binding Cassette Transporter A1) Suppresses TCR (T-Cell Receptor) Signaling and Provides Protection Against Atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: October 17, 2022

Showing 1-12 of 106

Last Updated: 09/26/2026